bioAffinity Technologies, Inc. Cash and Cash Equivalents
bioAffinity Technologies, Inc. (BIAF) had Cash and Cash Equivalents of $2.43 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash and Cash Equivalent
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-07
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $2.43M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $3.10M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $6.45M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $7.67M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2026-06-30 | $2.43M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $3.10M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $6.45M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $7.67M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $802.84K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $444.71K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $1.11M 10-K · filed 2026-03-16 |
| 2024-09-30 | $756.58K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $801.31K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $2.45M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $2.82M 10-K · filed 2025-03-31 |
| 2023-09-30 | $4.51M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $8.28M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $9.77M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $11.41M 10-K · filed 2024-04-01 |
| 2022-09-30 | $13.50M 10-Q · filed 2022-11-14 |
| 2021-12-31 | $1.36M 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |